Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Verdonck

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Cancer Research|July 1, 1990
Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipidL F Verdonck, E O Witteveen, H G van Heugten, et al.
Blood|November 14, 1997
Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantationH M Lokhorst, A Schattenberg, J J Cornelissen, et al.
Blood|February 1, 1990
A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantationL F Verdonck, G C de Gast, H G van Heugten, et al.
British Journal of Haematology|May 1, 1985
Transient expression of a second monoclonal component in two forms of biclonal gammopathyE J Bast, C M Slaper-Cortenbach, L F Verdonck, et al.
Bone Marrow Transplantation|April 1, 1992
The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservationL F Verdonck, E C Heesbeen, H G van Heugten, et al.
The American Journal of Pathology|April 1, 1988
Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survivalH J Schuurman, W Huppes, L F Verdonck, et al.
Lancet (London, England)|March 23, 1996
Graft-versus-myeloma effect in two casesL F Verdonck, H M Lokhorst, A W Dekker, et al.
Journal of Analytical Toxicology|November 1, 1980
Gas chromatographic determination of buformin in body fluids and tissues, using a nitrogen phosphorus detector: application to a postmortem caseG De Groot, R A Maes, B Sangster, et al.
Blood|November 14, 1997
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphomaL F Verdonck, A W Dekker, H M Lokhorst, et al.
Bone Marrow Transplantation|September 1, 1995
Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL)C A Uyl-de Groot, A Hagenbeek, L F Verdonck, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Cancer Research|July 1, 1990
Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipidL F Verdonck, E O Witteveen, H G van Heugten, et al.
Blood|November 14, 1997
Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantationH M Lokhorst, A Schattenberg, J J Cornelissen, et al.
Blood|February 1, 1990
A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantationL F Verdonck, G C de Gast, H G van Heugten, et al.
British Journal of Haematology|May 1, 1985
Transient expression of a second monoclonal component in two forms of biclonal gammopathyE J Bast, C M Slaper-Cortenbach, L F Verdonck, et al.
Bone Marrow Transplantation|April 1, 1992
The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservationL F Verdonck, E C Heesbeen, H G van Heugten, et al.
The American Journal of Pathology|April 1, 1988
Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survivalH J Schuurman, W Huppes, L F Verdonck, et al.
Lancet (London, England)|March 23, 1996
Graft-versus-myeloma effect in two casesL F Verdonck, H M Lokhorst, A W Dekker, et al.
Journal of Analytical Toxicology|November 1, 1980
Gas chromatographic determination of buformin in body fluids and tissues, using a nitrogen phosphorus detector: application to a postmortem caseG De Groot, R A Maes, B Sangster, et al.
Blood|November 14, 1997
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphomaL F Verdonck, A W Dekker, H M Lokhorst, et al.
Bone Marrow Transplantation|September 1, 1995
Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL)C A Uyl-de Groot, A Hagenbeek, L F Verdonck, et al.
Pageof 13